Materiality pending
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
- Conmed reported Q1 revenue of $312.27M, up 5.7% YoY with EPS of $0.79. - Revenue and EPS beat Zacks Consensus Estimates, with +1.70% and +6.76% surprises respectively. - Net Sales in Orthopedic and General Surgery segments increased year over year. - Shares of Conmed returned -7.5% over the past month, with Zacks Rank #3 (Hold). Price Impact Rating: Bearish Impact Horizon Rating: Short-term Type: Earnings
- Conmed reported Q1 revenue of $312.27M, up 5.7% YoY with EPS of $0.79.
- Revenue and EPS beat Zacks Consensus Estimates, with +1.70% and +6.76% surprises respectively.
- Net Sales in Orthopedic and General Surgery segments increased year over year.
- Shares of Conmed returned -7.5% over the past month, with Zacks Rank #3 (Hold).
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.